People & Place: Impacts on Substance Use and HIV Outcomes in Los Angeles
NCT ID: NCT07200973
Last Updated: 2025-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
250 participants
INTERVENTIONAL
2026-05-31
2028-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Peer Navigation and Contingency Management on Retention in HIV Care
NCT02310893
Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM
NCT01457066
Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
NCT01406626
Study of Recently HIV Infected Men and Transmission Behaviors
NCT01201083
Adherence Intervention for HIV-infected Drug Users
NCT02907697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The project represents a collaboration between researchers at University of California, Los Angeles (UCLA), the University of California, Santa Barbara (UCSB), and a local HIV clinic, bringing together expertise in medicine, public health, and community-based care. By combining academic research with input from patients and healthcare providers, this research aims to create practical and effective strategies for reducing barriers such as distance, transportation, and fragmented services, ultimately improving the accessibility, coordination and patient-centeredness of healthcare delivery for people living with HIV who also use substances.
Specific Aims include:
Aim 1. Connect existing policies and conditions (e.g., heat exposure, policing, and economic distribution) with geospatial patterns of health outcomes among people living with HIV via compilation of secondary data with new data collected among people living with HIV through an innovative "activity space" survey. These harmonized data will document spatial associations between local, state, and federal policies and contemporary contextual determinants of health at the neighborhood level and identify how perceptions of territorial reputations, and local spaces influence preferences for HIV care and SU harm reduction services.
Aim 2. Qualitatively assess the HIV and substance use care experience among people living with HIV (n=30) as well as staff members at a large HIV care clinic in LA (n=15) via qualitative interviews (N=45 total) to examine how experiences and perceptions of space influence service use and movement through HIV and substance use hotspots, in other words: the geography of care.
Aim 3. Adapt and pilot the evidenced based intervention, LINK LA (NCT01406626), to examine the role of a compatible peer case management intervention on HIV and substance use outcomes. Activities of this aim include: (a) undertaking a process of intervention adaptation utilizing results from qualitative interviews in Aim 2 with clinic staff and people living with HIV, and conduct theatre testing of the intervention, (b) piloting the adapted intervention among N=250 people living with HIV to assess acceptability and feasibility and assess the preliminary impacts of the adapted intervention on HIV and substance use outcomes, and (c) examining the relationship between the distance of where participants live and their choice of an enhanced HIV and substance use care experience based on an adapted intervention. Results will identify patterns in HIV and substance use care choices and outcomes across LAC's geographically broad neighborhoods and determine if an intervention can modify such choices and outcomes. The intervention is hypothesized to result in greater linkage to care, increased self-reported ART adherence, and decreased levels of HIV RNA viral load in comparison to pre-intervention periods.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adapted LINK-LA Peer Case Management
LINK-LA Peer Case Management Intervention, adapted for people living with HIV who use substances
Adapted LINK LA Peer Navigator
Our study will adapt the LINK LA peer navigation intervention (NCT01406626) for the current context (e.g., HIV care provision, substance use risk environments, etc.) and measure its effects on participants' HIV and substance care engagement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Adapted LINK LA Peer Navigator
Our study will adapt the LINK LA peer navigation intervention (NCT01406626) for the current context (e.g., HIV care provision, substance use risk environments, etc.) and measure its effects on participants' HIV and substance care engagement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Assigned male sex at birth
* Willing to return for follow-up study visits every six months as long as the study is ongoing and be available to return for all study visits, barring unforeseen circumstances
* Willing and able to provide written informed consent to take part in the study
* Willing and able to provide adequate information for locator purposes
* Willing to undergo repeat HIV viral load testing at select study visits
* Willing to undergo substance use testing at each study visit
Exclusion Criteria
* Unwilling or unable to provide reliable contact information
* Unwilling to provide urine or blood
* Any other condition or prior therapy that, in the opinion of the research staff would preclude informed consent, make study participation unsafe, make the individual unsuitable for the study or unable to comply with the study requirements. Such conditions may include, but are not limited to, renal, hepatic, hematological, gastrointestinal, endocrine, pulmonary, neurological, or cerebral disease, among others
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pamina Mae Gorbach
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.